-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Summit Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- Summit Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$768K, a 171% decline year-over-year.
- Summit Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$2.99M, a 60.3% increase year-over-year.
- Summit Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was -$5.28M, a 21.1% increase from 2022.
- Summit Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was -$6.69M, a 177% decline from 2021.
- Summit Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was -$2.42M, a 954% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)